Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CSBR
CSBR logo

CSBR Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Champions Oncology Inc (CSBR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Sell
Latest Price
5.880
1 Day change
0.51%
52 Week Range
9.630
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

CSBR is not a good buy right now for a beginner long-term investor with $50,000-$100,000 available. The stock is showing weak short-term momentum, no bullish proprietary signal, no supportive news catalyst, and options sentiment is bearish. Based on the current data, the better decision is to avoid buying now and wait for a clearer reversal or fundamental catalyst.

Technical Analysis

The technical picture is weak. Price closed at 5.85, just above support at 5.848, while MACD is negative and the histogram is still expanding lower, which points to ongoing downside momentum. RSI_6 at 31.384 is near oversold but not yet a clear reversal signal. Moving averages are converging, which suggests indecision rather than a confirmed uptrend. The stock is trading below the pivot level of 6.322, reinforcing the bearish near-term structure.

Options Data

Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is bearish. The open interest put-call ratio of 3.27 shows puts significantly outweigh calls, indicating traders are positioned defensively. However, option volume is 0, so there is no strong active options flow confirming a fresh directional bet. Implied volatility is extremely high at 521.44 with IV percentile 99.2 and IV rank 83.76, meaning options are priced for very large moves, but current positioning still leans negative.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
10
Buy
2

Positive Catalysts

  • No recent news catalysts were provided, and there were no notable insider, hedge fund, or congress buying signals. The only mild positive is that price is sitting close to support, which could attract bargain interest if momentum stabilizes.

Neutral/Negative Catalysts

  • No news in the past week means no event-driven catalyst is supporting the share price. Hedge funds are neutral, insiders are neutral, and there is no recent congress trading activity. The stock trend model points to negative forward performance over the next day, week, and month. Options positioning is bearish with a high put-call ratio, and proprietary signals show no buy setup today.

Financial Performance

Latest quarter financial data was not available because the financial snapshot returned an error. As a result, there is no confirmed revenue or earnings growth evidence to support a long-term buy decision.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target trend data was provided, so there is no visible Wall Street upgrade cycle or bullish target revision supporting the stock. The available read from pros is neutral to negative: no insider accumulation, no hedge fund accumulation, and no supportive catalyst flow.

Wall Street analysts forecast CSBR stock price to rise
1 Analyst Rating
Wall Street analysts forecast CSBR stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 5.850
sliders
Low
12
Averages
12
High
12
Current: 5.850
sliders
Low
12
Averages
12
High
12
No data

No data

People Also Watch